Efficacy and Safety of adding Fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by Pravastatin 40 mg monotherapy
Farnier, Ducobu, Bryniarski, Efficacy and Safety of adding Fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by Pravastatin 40 mg monotherapy, American Journal of Cardiology, May 2010 https://www.ajconline.org/article/S0002-9149(10)01041-6/fulltext https://download.journals.elsevierhealth.com/pdfs/journals/0002-9149/PIIS0002914910010416.pdf